AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,746 Cr | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr |
What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹5,746 Cr |
| Mar2024 | ₹4,817 Cr |
| Mar2023 | ₹4,466 Cr |
| Mar2022 | ₹4,012 Cr |
| Mar2021 | ₹3,503 Cr |
How is Sundry Debtors of AUROBINDO PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,746 Cr | 19.29 | |
| Mar2024 | ₹4,817 Cr | 7.84 | |
| Mar2023 | ₹4,466 Cr | 11.32 | |
| Mar2022 | ₹4,012 Cr | 14.53 | |
| Mar2021 | ₹3,503 Cr | - | |
Compare Sundry Debtors of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,430.7 Cr | 0.2% | 0.4% | -1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.2% |
0.4% |
-1.9% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses